Modeling a Genetic Risk for Schizophrenia in iPSCs and Mice Reveals Neural Stem Cell Deficits Associated with Adherens Junctions and Polarity

Cited by (240)

Items 101–200 of 240

1. Decoding the non‐coding genome: elucidating genetic risk outside the coding genome
   Cathy L. Barr, Virginia L. Misener · 2015 · Genes Brain & Behavior
2. The Proteome of BLOC-1 Genetic Defects Identifies the Arp2/3 Actin Polymerization Complex to Function Downstream of the Schizophrenia Susceptibility Factor Dysbindin at the Synapse
   Avanti Gokhale, Cortnie L. Hartwig, Amanda A. H. Freeman, Ravi Das, Stephanie A. Zlatic, Rachel Vistein, Amelia M. Burch, Guillemette Carrot, Arielle F. Lewis, Sheldon Nelms et al. · 2016 · Journal of Neuroscience
3. Development of two-photon polymerised scaffolds for optical interrogation and neurite guidance of human iPSC-derived cortical neuronal networks
   James A Crowe, Ayman El-Tamer, David A. Nagel, Anastasia Koroleva, Jorge A. Madrid-Wolff, Omar E. Olarte, Sergei G. Sokolovsky, Estefanía Estévez-Priego, Adriaan-Alexander Ludl, Jordi Soriano et al. · 2020 · Lab on a Chip
4. Differential cell-type-expression of CYFIP1 and CYFIP2 in the adult mouse hippocampus
   Yinhua Zhang, Hyae Rim Kang, Kihoon Han · 2019 · Animal Cells and Systems
5. The Importance of Non-neuronal Cell Types in hiPSC-Based Disease Modeling and Drug Screening
   David M. Gonzalez, Jill K. Gregory, Kristen Brennand · 2017 · Frontiers in Cell and Developmental Biology
6. FMRP and CYFIP1 at the Synapse and Their Role in Psychiatric Vulnerability
   Clifton, Nicholas E., Thomas, Kerrie L., Wilkinson, Lawrence S., Hall, Jeremy, Trent, Simon · 2020 · Complex Psychiatry
7. Concise Review: Progress and Challenges in Using Human Stem Cells for Biological and Therapeutics Discovery: Neuropsychiatric Disorders
   David M. Panchision · 2016 · Stem Cells
8. Neogenin Recruitment of the WAVE Regulatory Complex to Ependymal and Radial Progenitor Adherens Junctions Prevents Hydrocephalus
   Conor J. O’Leary, C. Cathrin Nourse, Natalie K. Lee, Amanda White, Michael B. Langford, Kai Sempert, Stacey J. Cole, Helen M. Cooper · 2017 · Cell Reports
9. Advances in Cerebral Organoid Systems and their Application in Disease Modeling
   Liu, Fangkun, Huang, Jing, Zhang, Liyang, Chen, Jindong, Zeng, Yu, Tang, Yongjian, Liu, Zhixiong · 2019 · Neuroscience
10. From “Directed Differentiation” to “Neuronal Induction”: Modeling Neuropsychiatric Disease
    Seok‐Man Ho, Aaron Topol, Kristen Brennand · 2015 · Biomarker Insights
11. Modeling schizophrenia pathogenesis using patient-derived induced pluripotent stem cells (iPSCs)
    Haneul Noh, Zhicheng Shao, Joseph T. Coyle, Sangmi Chung · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
12. Accumulation of minor alleles and risk prediction in schizophrenia
    Pei He, Xiaoyun Lei, Dejian Yuan, Zuobin Zhu, Shi Huang · 2017 · Scientific Reports
13. Phosphorylation of CYFIP2, a component of the WAVE-regulatory complex, regulates dendritic spine density and neurite outgrowth in cultured hippocampal neurons potentially by affecting the complex assembly
    Yeunkum Lee, Doyoun Kim, Jae Ryun Ryu, Yinhua Zhang, Shinhyun Kim, Yoonhee Kim, Bokyoung Lee, Woong Sun, Kihoon Han · 2017 · Neuroreport
14. Stem cell models of schizophrenia, what have we learned and what is the potential?
    Mohsen Moslem, Jessica F. Olive, Anna Falk · 2018 · Schizophrenia Research
15. N eonatal mouse cortical but not isogenic human astrocyte feeder layers enhance the functional maturation of induced pluripotent stem cell‐derived neurons in culture
    Fritz Walter Lischka, Anastasia G. Efthymiou, Qiong Zhou, Michael D. Nieves, Nikki M. McCormack, Matthew D. Wilkerson, Gauthaman Sukumar, Clifton L. Dalgard, Martin L. Doughty · 2017 · Glia
16. Primary Cilia–An Underexplored Topic in Major Mental Illness
    Michal Pruski, Bing Lang · 2019 · Frontiers in Psychiatry
17. Application of Airy beam light sheet microscopy to examine early neurodevelopmental structures in 3D hiPSC-derived human cortical spheroids
    Dwaipayan Adhya, George Chennell, James A Crowe, Eva P. Valencia-Alarcón, James Seyforth, Neveen A. Hosny, Marina V. Yasvoina, Robert Forster, Simon Baron‐Cohen, Anthony Christopher Vernon et al. · 2021 · Molecular Autism
18. Potential diagnostic biomarkers for schizophrenia
    Weihua Yue, Hailiang Huang, Jubao Duan · 2022 · Medical Review
19. Current progress in understanding schizophrenia using genomics and pluripotent stem cells: A meta-analytical overview
    Ashwani Choudhary, David Peles, Ritu Nayak, Liron Mizrahi, Shani Stern · 2022 · Schizophrenia Research
20. Using mouse transgenic and human stem cell technologies to model genetic mutations associated with schizophrenia and autism
    David St Clair, Mandy Johnstone · 2018 · Philosophical Transactions of the Royal Society B Biological Sciences
21. Utilizing induced pluripotent stem cells (iPSCs) to understand the actions of estrogens in human neurons
    Carole Shum, Sara C. Macedo, Katherine M. Warre-Cornish, Graham D. Cocks, Jack Price, Deepak P. Srivastava · 2015 · Hormones and Behavior
22. In vivo modeling of neuronal function, axonal impairment and connectivity in neurodegenerative and neuropsychiatric disorders using induced pluripotent stem cells
    Joanna A. Korecka, Simon A. Levy, Ole Isacson A · 2015 · Molecular and Cellular Neuroscience
23. Investigation of de novo mutations in a schizophrenia case-parent trio by induced pluripotent stem cell-based in vitro disease modeling: convergence of schizophrenia- and autism-related cellular phenotypes
    Edit Hathy, Eszter Szabó, Nóra Varga, Zsuzsa Erdei, Csongor Tordai, Boróka Czehlár, Máté Baradits, Bálint Jezsó, Júlia Koller, László Nagy et al. · 2020 · Stem Cell Research & Therapy
24. ERVWE1 Reduces Hippocampal Neuron Density and Impairs Dendritic Spine Morphology through Inhibiting Wnt/JNK Non-Canonical Pathway via miR-141-3p in Schizophrenia
    Wei Yao, Ping Zhou, Qiujin Yan, Xiulin Wu, Yaru Xia, Wenshi Li, Xuhang Li, Fan Zhu · 2023 · Viruses
25. Stem Cell-Derived Neurons in the Development of Targeted Treatment for Schizophrenia and Bipolar Disorder
    Bradley Watmuff, Bangyan Liu, Rakesh Karmacharya · 2017 · Pharmacogenomics
26. Generation of Isogenic Controls for In Vitro Disease Modelling of X-Chromosomal Disorders
    Lisa Hinz, Stephanie D. Beekhuis-Hoekstra, Kyoko Watanabe, Daniëlle Posthuma, Vivi Majella Heine · 2018 · Stem Cell Reviews and Reports
27. Modeling the genetic complexity of Parkinson's disease by targeted genome edition in iPS cells
    Carles Calatayud, Giulia Carola, Antonella Consiglio, Ángel Raya · 2017 · Current Opinion in Genetics & Development
28. Current advancements of modelling schizophrenia using patient-derived induced pluripotent stem cells
    Ugne Dubonyte, Andrea Asenjo-Martínez, Thomas Mears Werge, Kasper Lage, Agnete Kirkeby · 2022 · Acta Neuropathologica Communications
29. Loss of Function in the Neurodevelopmental Disease and Schizophrenia-Associated Gene CYFIP1 in Human Microglia-like Cells Supports a Functional Role in Synaptic Engulfment
    Steven D. Sheridan, Joy E. Horng, Hana Yeh, Liam T. McCrea, Jennifer P Wang, Ting Fu, Roy H. Perlis · 2022 · Biological Psychiatry
30. Network-based drug repurposing for schizophrenia
    Trang T. T. Truong, Zoe Shih-Jung Liu, Bruna Panizzutti, Jee Hyun Kim, Olivia May Dean, Michael Berk, Ken R. Walder · 2024 · Neuropsychopharmacology
31. Application of induced pluripotent stem cells to understand neurobiological basis of bipolar disorder and schizophrenia
    Yaonan Liu, Si‐Yao Lu, Jun Yao · 2017 · Psychiatry and Clinical Neurosciences
32. Brain organoids: Establishment and application
    Hao Chen, Xin Jin, Tie Li, Zhuang Ye · 2022 · Frontiers in Cell and Developmental Biology
33. Cell migration in schizophrenia: Patient-derived cells do not regulate motility in response to extracellular matrix
    Jing Yang Tee, Ratneswary Sutharsan, Yongjun Fan, Alan Mackay‐Sim · 2017 · Molecular and Cellular Neuroscience
34. Enhanced Prefrontal Neuronal Activity and Social Dominance Behavior in Postnatal Forebrain Excitatory Neuron-Specific Cyfip2 Knock-Out Mice
    Yinhua Zhang, Rim Kang Hyae, Seung-Hyun Lee, Yoonhee Kim, Ruiying Ma, Chunmei Jin, Ji-Eun Lim, Seoyeon Kim, Yeju Kang, Hyojin Kang et al. · 2020 · Frontiers in Molecular Neuroscience
35. Copy Number Variations in DISC1 and DISC1-Interacting Partners in Major Mental Illness
    Mandy Johnstone, Alan W Maclean, Lien Heyrman, An‐Sofie Lenaerts, Annelie Nordin, Lars‐Göran Nilsson, Peter De Rijk, Dirk Goossens, Rolf Adolfsson, David M. St. Clair et al. · 2015 · Complex Psychiatry
36. Using hiPSCs to model neuropsychiatric copy number variations (CNVs) has potential to reveal underlying disease mechanisms
    Flaherty, Erin K., Brennand, Kristen J. · 2017 · Brain Research
37. Deficiency of the neurodevelopmental disorder-associated geneCyfip2alters the retinal ganglion cell properties and visual acuity
    Taro Chaya, Hiroshi Ishikane, Leah Rie Varner, Yuko Sugita, Yamato Maeda, Ryotaro Tsutsumi, Daisuke Motooka, Daisuke Okuzaki, Takahisa Furukawa · 2021 · Human Molecular Genetics
38. Prospects for Modeling Abnormal Neuronal Function in Schizophrenia Using Human Induced Pluripotent Stem Cells
    Iya Prytkova, Kristen Brennand · 2017 · Frontiers in Cellular Neuroscience
39. A Scaled Framework for CRISPR Editing of Human Pluripotent Stem Cells to Study Psychiatric Disease
    Dane Z. Hazelbaker, Amanda Beccard, Anne M. Bara, Nicole Dabkowski, Angelica Messana, Patrizia Mazzucato, Daisy Lam, Danielle K. Manning, Kevin C. Eggan, Lindy E. Barrett · 2017 · Stem Cell Reports
40. CRISPR/Cas: An intriguing genomic editing tool with prospects in treating neurodegenerative diseases
    Safikur Rahman, Manali Datta, Jihoe Kim, Arif Tasleem Jan · 2019 · Seminars in Cell and Developmental Biology
41. Probing the molecular and cellular pathological mechanisms of schizophrenia using human induced pluripotent stem cell models
    Rebecca Sebastian, Yoonjae Song, ChangHui Pak · 2022 · Schizophrenia Research
42. Advances in the understanding of the pathophysiology of schizophrenia and bipolar disorder through induced pluripotent stem cell models
    Andrea Perrottelli, Francesco Flavio Marzocchi, Edoardo Caporusso, Giulia Maria Giordano, Luigi Giuliani, Antonio Melillo, Pasquale Pezzella, Paola Bucci, Armida Mucci, Silvana Galderisi · 2024 · Journal of Psychiatry and Neuroscience
43. The translational potential of human induced pluripotent stem cells for clinical neurology
    Helen E. Devine, Rickie Patani · 2016 · Cell Biology and Toxicology
44. Leveraging genome-wide association and clinical data in revealing schizophrenia subgroups
    Liangying Yin, Eric F.C. Cheung, Ronald Yuk-Lun Chen, Emily Hoi-Man Wong, Pak Chung Sham, Hon‐Cheong So · 2018 · Journal of Psychiatric Research
45. Focus on Causality in ESC/iPSC-Based Modeling of Psychiatric Disorders
    Anke Hoffmann, Michael J. Ziller, Dietmar Spengler · 2020 · Cells
46. Persistent Cyfip1 Expression Is Required to Maintain the Adult Subventricular Zone Neurogenic Niche
    Habela, Christa Whelan, Yoon, Ki-Jun, Kim, Nam-Shik, Taga, Arens, Bell, Kassidy, Bergles, Dwight E., Maragakis, Nicholas J., Ming, Guo-li, Song, Hongjun · 2020 · The Journal of Neuroscience
47. Signal requirement for cortical potential of transplantable human neuroepithelial stem cells
    Balazs Viktor Varga, Maryam Faiz, Helena Pivoňková, Gabriel Khelifi, Huijuan Yang, Shangbang Gao, Emma Linderoth, Mei Zhen, Ragnhildur Thóra Káradóttir, Samer M. I. Hussein et al. · 2022 · Nature Communications
48. Synaptic activity: An emerging player in schizophrenia
    Anindita Sarkar, Maria Carolina Marchetto, Fred H. Gage · 2015 · Brain Research
49. A dangerous method? The use of induced pluripotent stem cells as a model for schizophrenia
    Benjamin M. Jacobs · 2015 · Schizophrenia Research
50. CYFIP1 Dosages Exhibit Divergent Behavioral Impact via Diametric Regulation of NMDA Receptor Complex Translation in Mouse Models of Psychiatric Disorders
    Kim, Nam-Shik, Ringeling, Francisca Rojas, Zhou, Ying, Nguyen, Ha Nam, Temme, Stephanie J., Lin, Yu-Ting, Eacker, Stephen, Dawson, Valina L., Dawson, Ted M., Xiao, Bo et al. · 2022 · Biological Psychiatry
51. Modeling neurodevelopmental and psychiatric diseases with human iPSCs
    Zhexing Wen · 2017 · Journal of Neuroscience Research
52. Neural Stem Cell Dysfunction in Human Brain Disorders
    Ewa Liszewska, Jacek Jaworski · 2018 · Results and problems in cell differentiation
53. Investigation of Schizophrenia with Human Induced Pluripotent Stem Cells
    Samuel K. Powell, Callan P. O’Shea, Sara Rose Shannon, Schahram Akbarian, Kristen Brennand · 2020 · Advances in neurobiology
54. Domain-Specific Cognitive Impairments in Humans and Flies With Reduced CYFIP1 Dosage
    Woo, Young Jae, Kanellopoulos, Alexandros K., Hemati, Parisa, Kirschen, Jill, Nebel, Rebecca A., Wang, Tao, Bagni, Claudia, Abrahams, Brett S. · 2019 · Biological Psychiatry
55. Induced Pluripotent Stem Cells: Global Research Trends
    Takaharu Negoro, Hanayuki Okura, Akifumi Matsuyama · 2017 · BioResearch open access
56. A Dishful of a Troubled Mind: Induced Pluripotent Stem Cells in Psychiatric Research
    Sára Kálmán, Edit Hathy, János Réthelyi · 2015 · Stem Cells International
57. Induced pluripotent stem cells from patients with focal cortical dysplasia and refractory epilepsy
    Daniel Rodrigo Marinowic, Fernanda Majolo, Alessandra Deise Sebben, Vinícius Duval da Silva, Tiago Giuliani Lopes, Eliseu Paglioli, André Palmini, Denise Cantarelli Machado, Jaderson Costa da Costa · 2017 · Molecular Medicine Reports
58. CRISPR-based functional evaluation of schizophrenia risk variants
    Prashanth Rajarajan, Erin K. Flaherty, Schahram Akbarian, Kristen Brennand · 2019 · Schizophrenia Research
59. Human induced pluripotent stem cells technology in treatment resistant depression: novel strategies and opportunities to unravel ketamine’s fast-acting antidepressant mechanisms
    Matteo Marcatili, Carlo Sala, Antonios Dakanalis, Fabrizia Colmegna, Armando D’Agostino, Orsola Gambini, Bernardo Maria Dell’Osso, Beatrice Benatti, Luciano Conti, Massimo Clerici · 2020 · Therapeutic Advances in Psychopharmacology
60. Regulation of Cell Delamination During Cortical Neurodevelopment and Implication for Brain Disorders
    Godwin Sokpor, Beate Brand‐Saberi, Huu Phuc Nguyen, Tran Tuoc · 2022 · Frontiers in Neuroscience
61. High-content synaptic phenotyping in human cellular models reveals a role for BET proteins in synapse assembly
    Martin H. Berryer, Gizem Rizki, Anna J. Nathanson, Jenny A. Klein, Darina Trendafilova, Sara G. Susco, Daisy Lam, Angelica Messana, Kristina M. Holton, Kyle W. Karhohs et al. · 2023 · eLife
62. Role of adherens junctions and apical-basal polarity of neural stem/progenitor cells in the pathogenesis of neurodevelopmental disorders: a novel perspective on congenital Zika syndrome
    Felipe A. Bustamante, María Paz Miró, Zahady D. Velásquez, Luis Molina, Pamela Ehrenfeld, Francisco J. Rivera, Luis Federico Bátiz · 2019 · Translational research
63. Control of microglial dynamics by Arp2/3 and the autism and schizophrenia-associated protein Cyfip1
    Drew, James, Arancibia-Carcamo, I. Lorena, Jolivet, Renaud, Lopez-Domenech, Guillermo, Attwell, David, Kittler, Josef T. · 2020
64. Impaired oxysterol-liver X receptor signaling underlies aberrant cortical neurogenesis in a stem cell model of neurodevelopmental disorder
    Daniel Cabezas de la Fuente, Claudia Tamburini, Emily Stonelake, William James Griffiths, Jérémy Hall, Michael John Owen, David E.J. Linden, Andrew J. Pocklington, Yuqin Wang, Meng Li · 2024 · Cell Reports
65. Antiviral immunity within neural stem cells distinguishes Enterovirus-D68 strain differences in forebrain organoids
    Christine Vazquez, Seble G. Negatu, Carl Bannerman, Sowmya Sriram, Guo‐li Ming, Kellie A. Jurado · 2024 · Journal of Neuroinflammation
66. Cellular models to study schizophrenia: A systematic review
    Manasa Seshadri, Debanjan Banerjee, Biju Viswanath, K Ramakrishnan, Meera Purushottam, Ganesan Venkatasubramanian, Sanjeev Jain · 2016 · Asian Journal of Psychiatry
67. Investigating pediatric disorders with induced pluripotent stem cells
    Matthew D. Durbin, Adrian Gabriel Cadar, Young Wook Chun, Charles C. Hong · 2018 · Pediatric Research
68. Disease Modeling of Neuropsychiatric Brain Disorders Using Human Stem Cell-Based Neural Models
    Johanna Kaindl, Beate Winner · 2019 · Current topics in behavioral neurosciences
69. Understanding neurodevelopmental disorders using human pluripotent stem cell‐derived neurons
    Claudia Tamburini, Meng Li · 2017 · Brain Pathology
70. Conservation of neural progenitor identity and the emergence of neocortical neuronal diversity
    Belal Shohayeb, Zukhrofi Muzar, Helen M. Cooper · 2021 · Seminars in Cell and Developmental Biology
71. The Use of Stem Cell-Derived Neurons for Understanding Development and Disease of the Cerebellum
    Sam Nayler, Esther B. E. Becker · 2018 · Frontiers in Neuroscience
72. Studying Abnormal Chromosomal Diseases Using Patient-Derived Induced Pluripotent Stem Cells
    Yohei Hayashi, Miho Takami, Mami Matsuo‐Takasaki · 2020 · Frontiers in Cellular Neuroscience
73. Low-Density Neuronal Cultures from Human Induced Pluripotent Stem Cells
    Peter Michael Dimitrion, Yun Zhi, Dennis R. Clayton, Gerard L. Apodaca, Madeleine R. Wilcox, Jon W. Johnson, Vishwajit Laxmikant Nimgaonkar, Leonardo D’Aiuto · 2017 · Complex Psychiatry
74. Induced pluripotent stem cells for 2D and 3D modelling the biological basis of schizophrenia and screening possible therapeutics
    Eva Tomaskovic‐Crook, Kyle Guerrieri-Cortesi, Jeremy Micah Crook · 2021 · Brain Research Bulletin
75. Modeling schizophrenia with iPS cell technology and disease mouse models
    Takanobu Nakazawa · 2021 · Neuroscience Research
76. Human Induced Pluripotent Stem Cells: Now Open to Discovery
    Omer Durak, Li‐Huei Tsai · 2014 · Cell stem cell
77. In vivo and ex vivo gene therapy for neurodegenerative diseases: a promise for disease modification
    Pouyan Ebrahimi, Elham Davoudi, Razieh Sadeghian, Amin Zaki Zadeh, Emran Razmi, Reza Heidari, Mohammad Hossein Morowvat, Issa Sadeghian · 2024 · Naunyn-Schmiedeberg s Archives of Pharmacology
78. Hypoxic Preconditioned Neural Stem Cell-Derived Extracellular Vesicles Contain Distinct Protein Cargo from Their Normal Counterparts
    Tahereh Gharbi, Chang Liu, Haroon Latif Khan, Zhijun Zhang, Guo‐Yuan Yang, Yaohui Tang · 2023 · Current Issues in Molecular Biology
79. Induced pluripotent stem cells (iPSCs) as model to study inherited defects of neurotransmission in inborn errors of metabolism
    Sabine Jung‐Klawitter, Thomas Opladen · 2018 · Journal of Inherited Metabolic Disease
80. From Schizophrenia Genetics to Disease Biology: Harnessing New Concepts and Technologies
    Jubao Duan, Alan R. Sanders, Pablo V. Gejman · 2019 · Journal of Psychiatry and Brain Science
81. Using Two- and Three-Dimensional Human iPSC Culture Systems to Model Psychiatric Disorders
    Kimberly M. Christian, Hongjun Song, Guo‐li Ming · 2020 · Advances in neurobiology
82. The autism-associated gene SYNGAP1 regulates human cortical neurogenesis
    Marcella Birtele, Ashley Del Dosso, Tiantian Xu, Tuan N. Nguyen, Brent Wilkinson, Negar Hosseini, Sarah C. Nguyen, Jean‐Paul Urenda, Gavin T. Knight, Camilo Rojas et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
83. Disrupted mossy fiber connections from defective embryonic neurogenesis contribute to SOX11-associated schizophrenia
    Xianmixinuer Abulaiti, Ai‐Fang Wang, Han Zhang, Hang Su, Rui Gao, Jiayu Chen, Shaorong Gao, Lingsong Li · 2022 · Cellular and Molecular Life Sciences
84. Beyond the Global Brain Differences: Intraindividual Variability Differences in 1q21.1 Distal and 15q11.2 BP1-BP2 Deletion Carriers
    Rune Bøen, Tobias Kaufmann, Dennis van der Meer, Oleksandr Frei, Ingrid Agartz, David J. Ames, Micael Andersson, Nicola J. Armstrong, Éric Artiges, Joshua Atkins et al. · 2023 · Biological Psychiatry
85. Induced Pluripotent Stem Cells Reveal Common Neurodevelopmental Genome Deprograming in Schizophrenia
    Sridhar Tatarao Narla, Brandon Decker, Pinaki Sarder, Ewa K. Stachowiak, Michal K. Stachowiak · 2018 · Results and problems in cell differentiation
86. Using Induced Pluripotent Stem Cells to Investigate Complex Genetic Psychiatric Disorders
    Stephanie J. Temme, Brady J. Maher, Kimberly M. Christian · 2016 · Current Behavioral Neuroscience Reports
87. Rare Copy Number Variants Reveal Critical Cell Types and Periods of Brain Development in Neurodevelopmental Disorders
    Susmita Malwade, Carl M. Sellgren, Navneet A. Vasistha, Konstantin Khodosevich · 2025 · Biological Psychiatry Global Open Science
88. Contribution of rare coding variants to microcephaly in individuals with neurodevelopmental disorders
    Jihoon G. Yoon, Hyunsoo Jang, Seungbok Lee, Se Song Jang, Soojin Park, Jaeso Cho, Min‐Ji Kim, Jiye Han, Hyounji Yun, Man Jin Kim et al. · 2025 · Genome Medicine
89. Altered development and network connectivity in a human neuronal model of 15q11.2 deletion-related neurodevelopmental disorders
    Christa Whelan Habela, Shiyu Liu, Arens Taga, Sean Oddoye, Raha Maryam Dastgheyb, Norman J. Haughey, Dwight E. Bergles, Hongjun Song, Guo‐li Ming, Nicholas John Maragakis · 2025 · Translational Psychiatry
90. Stem Cells to Inform the Neurobiology of Mental Illness
    Mandy Johnstone, Robert Francis Hillary, David St Clair · 2018 · Current topics in behavioral neurosciences
91. Epistasis in schizophrenia genetics: What's missing is not heritability
    Daniel R. Weinberger · 2014 · Schizophrenia Research
92. A Link between Genetic Disorders and Cellular Impairment, Using Human Induced Pluripotent Stem Cells to Reveal the Functional Consequences of Copy Number Variations in the Central Nervous System—A Close Look at Chromosome 15
    Alessia Casamassa, Daniela Ferrari, Maurizio Gelati, Massimo Carella, Angelo Luigi Vescovi, Jessica Diana Rosati · 2020 · International Journal of Molecular Sciences
93. HippoCA3mpal Stem Cell Models Expose Dysfunctional Circuits in Schizophrenia
    Mandy Johnstone, Rana Fetit · 2018 · Cell stem cell
94. Self and the Brain. The Immune Metaphor
    Silvia Sánchez‐Ramón, Florence Faure · 2020 · Frontiers in Psychiatry
95. The Perspectives of Early Diagnosis of Schizophrenia Through the Detection of Epigenomics-Based Biomarkers in iPSC-Derived Neurons
    Davin Lee, Jinsoo Seo, Hae chan Jeong, Hyosang Lee, Sung Bae Lee · 2021 · Frontiers in Molecular Neuroscience
96. Using Human Induced Neural Precursor Cells to Define Early Neurodevelopmental Defects in Syndromic and Idiopathic Autism
    Robert Connacher, Emanuel M. DiCicco-Bloom, James H. Millonig · 2018 · Current Pharmacology Reports
97. Induced pluripotent stem cell technology: venturing into the second decade
    Yanhong Shi, Haruhisa Inoue, Jun B. Takahashi, Shinya Yamanaka · 2020 · Elsevier eBooks
98. Shedding light on latent pathogenesis and pathophysiology of mental disorders: The potential of iPS cell technology
    Yuko Arioka, Hiroki Okumura, Hideya Sakaguchi, Norio Ozaki · 2023 · Psychiatry and Clinical Neurosciences
99. Metergoline Shares Properties with Atypical Antipsychotic Drugs Identified by Gene Expression Signature Screen
    Chiara C. Bortolasci, Emily Joy Jaehne, Damián Hernández, Briana Spolding, Timothy Connor, Bruna Panizzutti, Olivia May Dean, Tamsyn M. Crowley, Alison Ruth Yung, Laura J. Gray et al. · 2023 · Neurotoxicity Research
100. Patient iPSCs: a new discovery tool for Smith-Lemli-Opitz syndrome
     Zhexing Wen, Hongjun Song, Guo‐li Ming · 2016 · Nature Medicine